| Effective | Test | Type | Description |
|---|
| 11/19/08 | Total CK with Relative Index (RCK) | Other | Test is no longer just for reflex testing, it can be ordered by physicians/clients |
| 11/18/08 | Chlamydia/GC by Target Amplified Nucleic Acid Probe (CGPT) | Specimen Requirements | Updated collect for the first voided urine to 20 - 30 mL from 15 - 20 mL. |
| 11/18/08 | GC by Target Amplified Nucleic Acid Probe (NGPT) | Specimen Requirements | Updated collect for the first voided urine to 20 - 30 mL from 15 - 20 mL. |
| 11/18/08 | Red Blood Cell Antibody Titer (TTR) | Other | Added Synonyms of AB Titer, Anti D Titer, Anti K Titer, Anti E Titer, and Anti Kell Titer. Also added Order Remark of "Order Antibody Screen with all titer requests." |
| 11/18/08 | Chlamydia by Target Amplified Nucleic Acid Probe (CTPT) | Specimen Requirements | Updated collect for the first voided urine to 20 - 30 mL from 15 - 20 mL. |
| 11/8/08 | Comprehensive Metabolic Panel with CBCA, Lipid Panel and TSH (CMPHTC) | Other | Corrected reported as name from LIPPNL to LIPDPL. |
| 11/5/08 | Immunofixation Electro, Serum w/IgG,A,M (SIFEMX) | Component Change | added KAPPA/ LAMBDA to package |
| 11/5/08 | Plasma Cell Profile (PCMX) | Component Change | added KAPPA/LAMBDA to package |
| 11/4/08 | Estradiol (ESTD) | Reference Interval | updated reference range |
| 10/29/08 | GC by Target Amplified Nucleic Acid Probe (NGPT) | Specimen Requirements | Added to unacceptable: 'Swab transport tubes submitted with white cleaning swab.
Swab transport tubes submitted with two swabs.
Swab transport tubes submitted without blue swab.' |
| 10/28/08 | Chlamydia/GC by Target Amplified Nucleic Acid Probe (CGPT) | Specimen Requirements | Added to unacceptable: 'Swab transport tubes submitted with white cleaning swab.
Swab transport tubes submitted with two swabs.
Swab transport tubes submitted without blue swab.' |
| 10/28/08 | Influenza Rapid Antigen (FLUAG) | Specimen Requirements | Added to collect: 'Nasal swabs also accepted but not recommended.' |
| 10/28/08 | Chlamydia by Target Amplified Nucleic Acid Probe (CTPT) | Specimen Requirements | Added to unacceptable: 'Swab transport tubes submitted with white cleaning swab.
Swab transport tubes submitted with two swabs.
Swab transport tubes submitted without blue swab.' |
| 10/28/08 | Culture, MRSA (CMRSA) | Specimen Requirements | Added to transport: 'Urine in a sterile leak-proof container, refrigerated or urine in a gray top boric acid preservative tube, ambient.' |
| 10/23/08 | Metals Panel 2, Blood (HM2) | Other | Required information added: 'Include patient demographics on requisition or complete a pink Blood Lead Report form.' |
| 10/23/08 | Metals Panel 1, Blood (HM1) | Other | Required information added: 'Include patient demographics on requisition or complete a pink Blood Lead Report form.' |
| 10/14/08 | CMV Antibody, IgM (CMVMAB) | Other | Test performanc. Updated days performed and reporting time |
| 10/2/08 | Estrogens, Serum Fractionated (ESFR) | Specimen Requirements | Removed alternate specimen type, royal blue (sodium heparin) 7.0 mL, from collect.
Transport updated to 0.5 mL (min 0.3 mL) from 1.0 mL (min 0.5 mL)
Removed from transport: 'Critical: Specimen must be frozen.'
Stability updated: Ambient to 2 days from 2 hours; refrigerated to 1 week from 2 days; frozen to 1 month from 3 months. |
| 10/1/08 | HBV Quantitation (HBVQTM) | Specimen Requirements | Unacceptable conditions added: Heparinized samples; whole blood samples; "Z" serum clot activator tubes. |
| 10/1/08 | NMR LipoProfile (NMRLP) | Specimen Requirements | Added to transport: "Ship to reference lab only Monday - Thursday.
Do not ship Friday, weekends, holidays or eve of a holiday to reference lab." |
| 9/30/08 | Potassium (K) | Reference Interval | Updated adult ref range from 3.5-5.0 to 3.5-5.1 |
| 9/26/08 | Vitamin K1, Plasma or Serum (VITKR) | Specimen Requirements | Transport temperature changed from Refrigerated to Frozen |
| 9/26/08 | Soluble Transferrin Receptor (STRECR) | Specimen Requirements | Transport temperature changed from Refrigerated to Frozen |
| 9/26/08 | HBV Quantitation (HBVQTM) | Specimen Requirements | Removed also acceptable red gel, ONLY EDTA Lave is acceptable. |
| 9/22/08 | Cystic Fibrosis Mutation Panel (CFSCNR) | Specimen Requirements | Removed from unacceptable: serum samples and severely hemolyzed samples.
Stability updated: Ambient to 3 days from 24 hours and refrigerated to 1 week from 5 days. |
| 9/22/08 | GM1 Antibody Panel (GM1R) | Specimen Requirements | Updated collect to red gel 4.0 mL from 8.0 mL.
To transport added: 'CRITICAL: Specimen must be frozen.'
Added to unacceptable body fluids and heat inactivated specimens.
Removed from frozen stability: 'Avoid repeated freeze/thaw cycles.' |
| 9/22/08 | BK Virus DNA, Quantitation (BKVR) | Specimen Requirements | Collect updated to lavender (EDTA) 3.0 mL. from 6.0 mL. |
| 9/22/08 | Fatty Acids, Very Long Chain (VLCFAR) | Specimen Requirements | Added patient preparation: 'Fasting specimen is preferred.'
To transport added: 'Also acceptable 3.0 mL whole blood ambient.' |
| 9/18/08 | Stool for WBC'S (STWBC) | Reference Interval | Changed referance range from None Seen to Negative and stability to 48 hrs |
| 9/18/08 | Low Molecular Weight Heparin (LMWH) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Removed from collect: 'Centrifuge blue top and freeze plasma within 30 minutes of draw.'
Removed from transport: '2 - 1.0 mL aliquots)
To transport, added 'Plasma must be separated within one hour of collection.' and added 'Submit a separate aliquot for each test requiring a frozen specimen.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.'
Stability updated: removed refrigerated 4 hours and changed frozen to 30 days. |
| 9/18/08 | Factor XI Activity (FAC11) | Specimen Requirements | Updated collect to 3.5 mL (3.2% sodium citrate) from 3.1 mL.
Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours.
|
| 9/18/08 | Factor VIII Activity (FAC8) | Specimen Requirements | Updated collect to 3.5 mL (3.2% sodium citrate) from 3.1 mL
Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours. |
| 9/18/08 | Fecal Occult Blood, Tube Test (IFOB) | Other | updated Stability in regards of a Raw stool sample |
| 9/18/08 | Factor X Activity (FAC10) | Specimen Requirements | Updated collect to 3.5 mL (3.2% sodium citrate) from 3.1 mL.
Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Specimen not received in appropriate transport media.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours. |
| 9/18/08 | Factor IX Activity (FAC9) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Removed from transport: 'If unable to deliver within 4 hours of collection, submit 2 - 1.0 mL aliquots of citrated frozen plasma.'
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours.
|
| 9/18/08 | Plasminogen Activity (PLG) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
To transport, added 'Plasma must be separated within one hour of collection.'
Removed from transport: 'If unable to deliver within 4 hours of collection, submit 2 - 1.0 mL aliquots of citrated frozen plasma.'
Unacceptable conditions added.
Frozen stability added. |
| 9/18/08 | Antithrombin III Activity (AT3A) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
To transport, added 'Plasma must be separated within one hour of collection.'
Removed from transport: 'If unable to deliver within 4 hours of collection, submit 2 - 1.0 mL aliquots of citrated frozen plasma.'
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours. |
| 9/18/08 | Factor V Activity (FAC5) | Specimen Requirements | Updated collect to 3.5 mL (3.2% sodium citrate) from 3.1 mL.
Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours.
|
| 9/18/08 | Factor VII Activity (FAC7) | Specimen Requirements | Updated collect to 3.5 mL (3.2% sodium citrate) from 3.1 mL.
Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours.
|
| 9/18/08 | Factor VIII Inhibitor Assay (F8INH) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Updated transport to platelet poor plasma.
To transport, added 'Plasma must be separated within one hour of collection.' and directions for platelet poor plasma.
Removed from transport: 'If unable to deliver within 4 hours of collection, submit 2 - 1.0 mL aliquots of citrated frozen plasma.'
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.' Removed: 'Delayed transport to lab.'
Stability updated: Removed ambient 4 hours and refrigerated 4 hours.
|
| 9/18/08 | Heparin Level (HEPL) | Specimen Requirements | Added to collect: 'Venipuncture must not be traumatic or slow flowing. Always draw a discard tube prior to blue tube. Recommend white or blue top tube for discard.'
Removed from collect: "Centrifuge blue top and freeze plasma within 30 minutes of draw.'
To transport, added 'Plasma must be separated within one hour of collection.' and added 'Submit a separate aliquot for each test requiring a frozen specimen.'
Unacceptable conditions updated: Added: 'Plasma stored in glass tubes.'
Stability updated: removed refrigerated 4 hours and changed frozen to 30 days. |
| 9/17/08 | Creatine Kinase Isoenzymes (CKISR) | Specimen Requirements | Changed draw specimen from a green top to a Red Gel |
| 9/16/08 | Fibrinogen Activity (FBGN) | Reference Interval | Updated Reference range |
| 9/16/08 | Partial Thromboplastin Time (PTT) | Reference Interval | Updated Reference ranges |
| 9/12/08 | Microalbumin, Urine Random (MAR) | Specimen Requirements | Updated transport to two 5mL aliquots. Was just one 10 mL sample. |
| 9/12/08 | Homocysteine, Total (HMCY) | Other | added Interpretive information |
| 9/4/08 | Respiratory Syncytial Virus Antigen Screen (RSVAG) | Other | Added the following Order Remark: The use of rapid influenza and RSV viral antigen assays is strongly discouraged during nonepidemic periods (historically late September through March) due to unacceptably low positive predictive values. We recommend ordering the Respiratory Viral Panel by RT-PCR (ACL test code RVPN) which has much higher positive and negative predictive values during nonepidemic periods. |
| 9/4/08 | Influenza Rapid Antigen (FLUAG) | Other | Revised Order Remark. Removed the following: During periods of low prevalence in the community, the positive predictive value of this test is low. Positive results should be confirmed by other methods. Added the Following: The use of rapid influenza and RSV viral antigen assays is strongly discouraged during nonepidemic periods (historically late September through March) due to unacceptably low positive predictive values. We recommend ordering the Respiratory Viral Panel by RT-PCR (ACL test code RVPN) which has much higher positive and negative predictive values during nonepidemic periods. |
| 9/4/08 | Chlamydia by Target Amplified Nucleic Acid Probe (CTPT) | Name Change | Long Test Name updated from: Chlamydia/GC to Chlamydia. |
| 9/3/08 | Culture, Blood Isolator (BLDC) | Specimen Requirements | Added to collect: ' Adult draws for patients greater than 12 years old: 10 mL isolator tube.
Pediatric patients less than or equal to 12 years old: 1.5 mL pediatric isolator tube.'
Added to unacceptable conditions: '10 mL isolator tube with less than 5 mL of blood.
1.5 mL pediatric isolator tube with less than 0.5 mL of blood.' |
| 9/3/08 | Creatinine (CREATG) | Other | Updated interpretive info and removed info regarding >70 years of age. ACL is reporting this value out again. Added disclaimer regarding MDRD and patients >70. |
| 8/26/08 | Vaginal Pathogens DNA Direct Probes (VAGPTH) | Other | Added information link to Clinical Significance field. |
| 8/25/08 | Mononucleosis Screen without Reflex to Epstein-Barr Virus Antibody (MONO) | Other | Added Clinical Significance: The laboratory diagnosis of Infectious Mononucleosis (IM) is based on the detection of heterophile antibodies produced in response to the Epstein - Barr Virus (EBV), the causative agent in IM. A heterophile antibody response is observed in 80 - 90% of adults and children with EBV. This percentage drops to approximately 50% for children under four years of age, as most infants and young children do not make heterophile antibodies. |
| 8/25/08 | Mononucleosis Screen without Reflex to Epstein-Barr Virus Antibody (MONO) | Other | Added the following Order Remark: Test Order Recommendation: Appropriate for ages 5 years and older. No reflex to Epstein - Barr Virus Antibody. |
| 8/25/08 | Mononucleosis Screen with Reflex to Epstein-Barr Virus Antibody (MONORX) | Other | Updated Order Information with the following statement: Test Order Recommendation: Appropriate for ages 4 years and younger. Negative results will reflex to Epstein-Barr Virus Antibody. |
| 8/25/08 | Mononucleosis Screen with Reflex to Epstein-Barr Virus Antibody (MONORX) | Other | Added Clinical Significance Information: The laboratory diagnosis of Infectious Mononucleosis (IM) is based on the detection of heterophile antibodies produced in response to the Epstein - Barr Virus (EBV), the causative agent in IM. A heterophile antibody response is observed in 80 - 90% of adults and children with EBV. This percentage drops to approximately 50% for children under four years of age, as most infants and young children do not make heterophile antibodies. |
| 8/22/08 | Chlamydia/GC by Target Amplified Nucleic Acid Probe (CGPT) | Specimen Requirements | No longer using Probe Tec culturette, now using APTIMA Unisex specimens Collection kit. |
| 8/22/08 | Chlamydia by Target Amplified Nucleic Acid Probe (CTPT) | Specimen Requirements | No longer using Probe Tec culturette, now using APTIMA Unisex specimens Collection kit. |
| 8/22/08 | Beta-hCG, Tumor Marker (HCGTM) | Other | Added Interpretive statement |
